The myelodysplastic syndromes.
نویسنده
چکیده
The concept of preleukaemia originated early in this century with the recognition of prodromal haematological abnormalities in acute myeloid leukaemia.' Since then similar preleukaemic disorders have 'been described, including primary acquired sideroblastic anaemia and smouldering or oligoblastic leukaemia. Confusion created by differing connotations placed on the term preleukaemia was resolved in 1982 by the introduction of a common nomenclature based on morphological criteria. Under the generic term of myelodysplastic syndromes five subgroups were defined: refractory anaemia; refractory anaemia with ring sidero-blasts; refractory anaemia with an excess of blasts; refractory anaemia with an excess' of blasts in transformation; and chronic myelomonocytic leukaemia.2 Other conditions associated with a risk of developing acute myeloid-leukaemia such as aplastic anaemia,. paroxysmal nocturnal haemo-globinuria, Down's syndrome, and chromosomal breakage syndromes are excluded. Though the myelodysplastic syndromes occur mainly in the elderly;, they have been increasingly recognised in younger patients, including children,3 and after chemo-therapy or radiotherapy for malignant and non-malignant disease.4 Cytopenia is a dominant feature, most patients presenting with anaemia, infection, bruising, or haemorrhage. The liver and the spleen may be enlarged, though not strikingly so except in chronic myelomonocytic leukaemia, where hypertrophy of'the gums, infiltrative skin lesions, lymphadenopathy, and, rarely, serous effusions also occur.5 6 Typically there is a combination of anaemia, neutropenia, and thrombocytopenia, though-in chronic myelomonocytic leukaemia there is a characteristic monocytosis and neutro-philia. Anaemia, usually macrocytic despite the absence of vitamin B12 or folic acid deficiency, is accompanied by a range of red cell abnormalities and hyposegmented (pseudo-Pelger) hypogranular neutrophils. The bone marrow reflects ineffective haemopoiesis'and shows characteristic morphological abnormalities of all cell lines. These features are mirrored by functional defects of the neutrophils and platelets, which contribute to the risk of infection and bleedmig.78 A variety of non-specific epiphenomena occur, including quantitative red cell enzyme abnormalities, low neutrophil alkaline phosphatase activity, raised fetal haemo-globin concentrations, altered expression of blood group antigens, and, rarely, a positive Ham's-test. Serum and urinary lysozyme activities are raised in chronic myelomono-cytic leukaemia. Non-random chromosome abnormalities occur in up to 79% of cases.9 Some of these have specific clinical correlations. For example, deletion of the long arm (q) of chromosome 5 is associated with a syndrome seen mainly in elderly women characterised by macrocytic anaemia, a normal or high platelet count, and long survival.'0 Recently myelodysplastic syndromes have been shown to coexist on occasions with proliferative disorders of B or T lymphoid cells, perhaps indicating involvement …
منابع مشابه
Range Determination of Antigen Expression in Myeloid, Erythroid and Lymphoid Cell Lineages among Patients with Myelodysplastic Syndrome
Background: Myelodysplastic syndrome is a mixed clonal disorder of bone marrow progenitor cells. Understanding the pattern of the different lineage-specific, immature, and mature markers in myelodysplastic syndrome will help in setting-up the frame of reference to diagnose. Patients and Methods: We compared 60 bone marrow samples from 30 newly-diagnosed patients with myelodysplastic syndrome ...
متن کاملGene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome
Myelodysplastic syndromes (MDSs) are a clonal bone marrow (BM) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (AML). Methylation silencing of HRK has been found in several human malignancies. In this study, we explored the association of HRK methylation status with its expression, clinical parameters and MDS subtypes in MDS pa...
متن کاملInfections in myelodysplastic syndromes.
Myelodysplastic syndromes are associated with a risk of severe infections. While neutropenia is likely to be the main predisposing factor, several other immune defects have been reported, including impaired neutrophil function, B-, T- and NK-cell defects and the possible consequences of iron overload due to red blood cell transfusions. The advanced age of most patients, their frequent comorbidi...
متن کاملIDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
BACKGROUND Myelodysplastic syndromes are a heterogeneous group of hematopoietic stem cell disorders with a high propensity to transform into acute myeloid leukemia. Heterozygous missense mutations in IDH1 at position R132 and in IDH2 at positions R140 and R172 have recently been reported in acute myeloid leukemia. However, little is known about the incidence and prognostic impact of IDH1 and ID...
متن کاملActivation of cytotoxic T-cell receptor gd T lymphocytes in response to specific stimulation in myelodysplastic syndromes
Results Vγ9Vδ2 T cells, the major circulating γδ T-cell subset, were reduced in myelodysplastic syndromes, but mainly in myelodysplastic syndromes’ patients with associated autoimmune diseases, suggesting that this anomaly was largely due to the autoimmune component. On the other hand, bromohalohydrin pyrophosphate-induced expansion of the Vγ9Vδ2 T-cell population in all 15 control samples, but...
متن کاملMutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
Therapy-related myelodysplastic syndromes and acute myelogenous leukemia comprise a poor-risk subset of myelodysplastic syndromes and acute myelogenous leukemia. Large-scale mutation profiling efforts in de novo myelodysplastic syndromes have identified mutations that correlate with clinical features, but such mutations have not been investigated in therapy-related myelodysplastic syndromes and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical and laboratory haematology
دوره 6 2 شماره
صفحات -
تاریخ انتشار 1984